Enhanced prolactin inhibition following chronic treatment with haloperidol and morphine.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D007031:Hypothalamus / Q000502:physiology; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D009434:Neural Pathways / Q000502:physiology; D011388:Prolactin / Q000097:blood*; D051381:Rats; D013375:Substance Withdrawal Syndrome / Q000097:blood*; D013788:Thalamus / Q000502:physiology
D009020:Morphine; D011388:Prolactin; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine